Mark Rothera, CCO at PTC Therapeutics, holds 100.00K shares in Viracta Therapeutics (Ticker: VIRX), holds 42.95K shares in PTC Therapeutics (Ticker: PTCT), holds 4.81K shares in Aegerion (Ticker: AEGR). Most recently, Mark Rothera Bought ― shares of Viracta Therapeutics on Dec 04, 2023 for an estimated value of 49.00K.
What is the percentage of profitable transactions made by Mark Rothera?
The percentage of profitable transactions made by Mark Rothera is 33%.
What is the average return per transaction made by Mark Rothera?
The average return per transaction made by Mark Rothera is -22.60%.
What stocks does Mark Rothera hold?
Mark Rothera holds: PTCT, VIRX, AEGR stocks.
What was Mark Rothera’s latest transaction?
Mark Rothera latest transaction was an Informative Buy of $49.00K.
What was Mark Rothera's most profitable transaction?
Mark Rothera’s most profitable transaction was an Informative Buy of PTCT stock on March 7, 2016. The return on the trade was 53.20%.
What is Mark Rothera's role in PTC Therapeutics?
Mark Rothera's role in PTC Therapeutics is CCO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.